Latest Report Available at Orbis research Biobanks Market provides pin-point analysis for changing competitive dynamics and a forward looking perspective on different factors driving or restraining industry growth.
The European biobanks market was valued at USD 57.72 million in 2014. It is expected to become a USD 77.94 million market by 2019. During this period, the market is expected to show a CAGR of 6.19%.
Europe Biobanks Market- Market Dynamics
Request sample copy of this report at Biobanks Market Research Report
The market in Europe is facilitated by a great number of collaborations and agreements between member organizations to facilitate good research in the field of biobanking.
Some of the factors leading to the growth of the biobanks market in Europe are:
The vision of personalized medicine
Poor productivity rate of the pharmaceutical industry with respect to the new drug approvals
Need to contain the ever-increasing healthcare costs
Research and development processes from early discovery through clinical trials
Advances in regenerative medicine, drug discovery and biobanking techniques
While there is ample scope for growth in Europebiobanks market, there are several factors restraining it. Some of these are:
Privacy ,confidentiality and surveillance issues
Access policies and procedures
Regulation-based issues with biobanking procedures
Fear of privatization
Lack of proper governance
Cost competitive procedures
The challenge for the future of biobanking within Europe is to develop meta level governance that supports a pan-European biobanking infrastructure. Currently, the regulatory systems are not favorable and this does not facilitate cutting edge research across borders in the most efficient and economical manner.
From the geographical point of view, European initiatives are leading the way in what's called harmonization, or making sure that all biobanks follow evidence-based standards for collecting, storing, and handling of specimens. From a market perspective, the UK is the major market in this segment with a share as high as 23%. Following the UK is Germany with the next biggest share.
Purchase a copy of Biobanks Market visit @ http://www.orbisresearch.com/contact/purchase/219620 For more information contact firstname.lastname@example.org
The biobanks market was segmented on the basis of the type of mechanism, equipment used, application in different sectors and geography.
Some of the key players in the market are:
WAK-Chemie Medical GmbH
deCODE Genetics, Inc.
Cell & Co Biorepository
What the Report Offers
Market Definition for European Biobanks market along with identification of key drivers and restraints for the market.
Market analysis for the European Biobanks market, with region-specific assessments and competition analysis on a European and regional scale.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a European and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their share of markets.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
An exhaustive understanding of the worldwide market for European Biobanks.
A comprehensive analysis of the major trends, innovations and associated prospects for market growth over the coming half a decade
An ideal opportunity for industry consultants, and other interested and allied parties to gain a critical insight into the factors driving and restraining the market, in addition to opportunities offered
Wide-ranging information provided about the leading market players and the major strategies adopted by them.
Browse Complete Report @ http://www.orbisresearch.com/reports/index/europe-biobanks-market-growth-trends-and-forecasts-2017-2022 .
Some points From TOC:
1.1 Report Description
1.2 Research Methodology
- EXECUTIVE SUMMARY
2.1 Key Findings
2.2 Market Overview
- MARKET OVERVIEW
3.1 Market Definition
3.2 Market Drivers
3.2.1 Investment by Government & Non-Governmental Organizations
3.2.2 Rise in Chronic Diseases
3.2.3 Advances in Regenerative Medicine
3.2.4 Advances in Drug Discovery & Development
3.3 Market Restraints
3.3.1 Regulatory Issues
3.3.2 Storage Problems
3.3.3 High-Cost techniques
- EUROPEAN MARKETS: SEGMENTATION BY TYPE
4.1 Optimized Pre-Formulated Media
4.2 Non-Optimized Isotonic Formulated Media
- EUROPEAN MARKETS: SEGMENTATION BY EQUIPMENT
5.2 Ice Machines
5.4 Cryogenic Storage Systems
5.5 Alarm Monitoring Systems
5.6 LN2 Supply Tanks
- EUROPEAN MARKETS: SEGMENTATION BY APPLICATION
6.1 Drug Discovery
6.2 Biobanking Procedures
6.3 Regenerative Medicine
- EUROPEAN MARKETS: SEGMENTATION BY GEOGRAPHY
- COMPETITIVE LANDSCAPE
8.2 Mergers & Acquisitions
8.4 New Product Launch
For any enquires before buying, connect with us @ email@example.com
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research
Follow us on Twitter: https://twitter.com/orbisresearch
Like us on Facebook: https://www.facebook.com/pages/Orbis-Research/820969017982115